PRL-3 was not detected in any of the clinical lung cancer samples assessed (n = 12), whereas PRL-3 was detected in 9 of 10 samples in the colorectal cancer specimens (from low- to high-level expression; Supplementary Figure S2). This evidence concerns the gene PTP4A3 and colorectal cancer.